Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a global leader in providing a wide range of scientific instruments, laboratory equipment, reagents, and consumables. The company operates through four main segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Its Life Sciences Solutions segment supports biological and medical research, drug and vaccine production, and disease diagnostics across various sectors, including pharmaceuticals and biotechnology. The Analytical Instruments segment offers advanced tools and services for laboratory and field applications, catering to diverse markets such as environmental and clinical laboratories. The Specialty Diagnostics segment provides a variety of immunodiagnostic products and healthcare solutions, while the Laboratory Products and Services segment supplies essential equipment and consumables for research and clinical laboratories. Founded in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is committed to enabling customers to enhance health, safety, and productivity through innovative technologies and services.

Daniella Cramp

Senior Vice President and President

Kent Davidson

Global Vice President Commercial

Glyn Davies

Vice President and GM, Semiconductor Materials and Structural Analysis

Alan J. Malus

President of the New Analytical Technologies Group

Jelto Swaving

Director of Business Management

72 past transactions

Solventum - Purification & Filtration Business

Acquisition in 2025
Solventum - Purification & Filtration Business is a unit of Solventum that offers filters and membranes for use in the manufacturing of biopharmaceutical and medical technologies, microelectronics food, beverage products, and drinking water.

miDiagnostics

Series D in 2024
miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

CytoReason

Series B in 2024
CytoReason specializes in developing a cell-centered computational model of the human body to analyze complex biological data. By gathering proprietary information from pharmaceutical companies, the organization simulates human diseases on a cellular level, allowing for detailed insights into tissue and cell interactions. Utilizing a robust database and an AI-driven platform, CytoReason enables pharmaceutical and biotech firms to uncover new opportunities, streamline clinical trial processes, lower development costs, and enhance the chances of regulatory approval. The company's approach leverages machine learning to reconstruct cellular data from bulk tissue and integrate multi-omics information, ultimately facilitating the discovery and development of targeted therapies tailored to specific patient needs.

Olink

Acquisition in 2023
Olink Holding AB is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

CorEvitas

Acquisition in 2023
CorEvitas is a provider of clinical registry data and analytics services focused on the biopharmaceutical sector. Established in 2000 and headquartered in Waltham, Massachusetts, the company specializes in delivering real-world evidence through its extensive registry data, which includes insights on patient experiences and outcomes. CorEvitas operates six autoimmune registries across the United States, Canada, and Japan, collecting data from over 400 participating investigator sites. The company ensures the accuracy and completeness of its data through rigorous quality control processes before it is stored in a secure data warehouse. Additionally, CorEvitas conducts active safety surveillance to support regulatory commitments for new drug approvals, contributing to post-authorization safety studies. The company's mission is to advance patient care and improve treatment through comprehensive real-world data analysis.

MarqMetrix

Acquisition in 2023
MarqMetrix, Inc. specializes in the development of optical sensor technology for various applications, including environmental, biological, chemical, and industrial sectors. The company creates optical measurement systems that deliver accurate and repeatable data at critical measurement points. By focusing on process improvement, MarqMetrix designs and develops advanced optical sensors and data analysis tools, alongside cloud-based systems. This enables businesses to achieve real-time monitoring and control, providing deeper insights and enhancing operational efficiency.

The Binding Site Group

Acquisition in 2022
Binding Site is a Specialist Protein company committed to the research, development, manufacture and distribution of innovative immunodiagnostic assays for the global laboratory market. With extensive expertise in antibody specificity technology, Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of patients across a range of cancers and immune system disorders.

Ionpath

Corporate Round in 2022
IonPath, Inc., based in Menlo Park, California, specializes in multiplexed ion beam imaging services for pathology. Founded in 2014, the company has developed advanced ion beam imaging technology that allows for detailed analysis of tissue biopsies, including fresh, frozen, and formalin-fixed paraffin-embedded (FFPE) samples. This technology goes beyond traditional light microscopy, providing a comprehensive understanding of the tissue microenvironment through highly multiplexed quantitative single-cell analysis. By enabling healthcare providers to obtain actionable insights, IonPath's services facilitate accurate cancer diagnoses and contribute to advancements in human health.

PeproTech

Acquisition in 2022
PeproTech, founded in 1988 by a group of scientists, specializes in the development and production of recombinant cytokines and growth factors for life-science research, cellular therapy, and regenerative medicine. The company offers a comprehensive range of products, including high-quality cytokines derived from E. coli, insect, and mammalian cells, monoclonal and polyclonal antibodies, ELISA development kits, and cell culture media and supplements. PeproTech has established a global distribution network with customer-service offices in multiple countries, including the US, UK, Germany, and China, and aims to expand into Australia and New Zealand. To meet the demands of current research, the company has enhanced its production capabilities with a 5000 sq. ft. animal-free manufacturing facility. PeproTech collaborates closely with researchers in academia and industry to adapt its product offerings and support specific research needs, ensuring it remains at the forefront of scientific advancements.

PharmaFluidics

Acquisition in 2021
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.

PharmaFluidics

Acquisition in 2021
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.

PPD

Acquisition in 2021
PPD, Inc. is a global provider of drug development services tailored for the biopharmaceutical industry. The company operates through two primary segments: Clinical Development Services and Laboratory Services. Its clinical development offerings encompass a wide range of services, including product development, consulting, and management of clinical trials spanning Phases II-IV, as well as medical communications and post-approval support. In addition, PPD's laboratory services include bioanalytical testing, biomarker research, vaccine science, and good manufacturing practices. With a commitment to enhancing the efficiency of drug development, PPD collaborates with various clients, including pharmaceutical, biotechnology, and medical device companies, as well as academic institutions and government organizations. Established in 1985, PPD is headquartered in Wilmington, North Carolina.

WuXi Diagnostics

Series B in 2021
WuXi Diagnostics is a provider of clinical diagnostic services that focuses on bridging the gap between research and clinical practice. The company offers a range of testing solutions, including screening and early diagnosis, clinical decision support, and prognosis management. By leveraging innovative models, WuXi Diagnostics aims to enhance diagnostic product innovation and generate valuable clinical insights. This approach is designed to improve health outcomes through precision diagnosis and treatment, ultimately benefiting patients and the broader healthcare community.

Mesa Biotech

Acquisition in 2021
Mesa Biotech, Inc. is a company focused on designing, developing, and manufacturing molecular diagnostic tests for infectious diseases. Founded in 2015 and based in San Diego, California, with a satellite laboratory in Santa Fe, New Mexico, Mesa Biotech has created a range of products, including the Accula Dock and various Accula test cassettes for influenza and respiratory syncytial virus. The company utilizes innovative technology that simplifies DNA and RNA testing, combining the convenience of rapid point-of-care tests with the sensitivity and specificity typically associated with laboratory-based molecular diagnostics. This approach allows healthcare professionals to obtain actionable, laboratory-quality results quickly and efficiently.

Henogen

Acquisition in 2021
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.

Phitonex

Acquisition in 2020
Phitonex, Inc. is a biotechnology company based in Durham, North Carolina, that specializes in the development of fluorescent reagents designed to enhance the analysis of molecular biomarkers. Founded in 2017 as a spin-out from Duke University, the company focuses on creating advanced fluorescent labels and instrumentation, including its proprietary products Novafluor, Infinifluor, and Infinisight. These innovative solutions enable high-resolution, high-throughput flow cytometry, allowing for the simultaneous observation of multiple biomarkers. Phitonex's technology offers a cost-effective and non-destructive approach to molecular analysis, streamlining experimental design and accelerating discovery processes in disease research. The co-founders bring over 15 years of experience in engineering molecular-level fluorescence properties, positioning Phitonex as a leader in the field. As of December 31, 2020, Phitonex operates as a subsidiary of Thermo Fisher Scientific Inc.

HighChem

Acquisition in 2019
HighChem Ltd. is a software development company based in Bratislava, Slovakia, specializing in mass spectrometry solutions. Founded in 1998, the company provides tools that empower chemists, medical researchers, and biologists to analyze complex analytical data effectively. HighChem's offerings include extensive libraries and cloud platforms, which encompass vast collections of fragmented information, experimental spectra, and organism-specific biochemical data. These resources are crucial for various applications in metabolomics, pharmacology, forensics, and environmental science. As of June 2019, HighChem operates as a subsidiary of Thermo Fisher Scientific Inc.

Brammer Bio

Acquisition in 2019
Brammer Bio, LLC specializes in the development and manufacturing of cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, and clinical and commercial supply of drug substances and formulated products. Brammer Bio focuses on supporting the production of autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications. With facilities in Alachua, Florida, and plans for a new site in Lexington, Massachusetts, the company aims to enhance its capacity for large-scale manufacturing and clinical support. As a contract development and manufacturing organization, Brammer Bio collaborates with biopharma clients to facilitate the delivery of innovative therapies, ensuring regulatory compliance and accelerating the commercialization of novel medicines.

IntegenX

Acquisition in 2018
IntegenX, Inc. specializes in developing human DNA identification solutions, particularly for forensics and law enforcement. The company utilizes advanced technology platforms that combine fluidics, optics, and biochemistry to create automated sample-to-answer products for DNA-based identity testing. Among its offerings are the RapidHIT System, which automates the production of standardized DNA profiles from various human samples, and the RapidHIT GlobalFiler Express Kit, designed for direct processing of crime scene samples. Additionally, IntegenX provides systems like the Apollo 100 and Apollo 200 for DNA sequencing and sample preparation. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and became a subsidiary of Thermo Fisher Scientific Inc. in 2018. The company's products are distributed internationally across various countries, enhancing their reach in the market for reliable DNA identification solutions.

Linkage Biosciences

Acquisition in 2017
Linkage Biosciences, Inc. is a molecular diagnostics company focused on developing and marketing products that enhance and accelerate complex genetic testing. Established in 2004 and headquartered in South San Francisco, California, with an office in Geneva, Switzerland, the company specializes in human leukocyte antigen (HLA) testing products used primarily in solid organ and hematopoietic stem cell transplantation. Its product offerings include a range of HLA typing kits, killer-cell immunoglobulin-like receptor (KIR) typing kits, and human platelet antigen (HPA) typing kits, along with accessories to facilitate testing procedures. Linkage Biosciences aims to improve diagnostic capabilities in areas such as autoimmune disease testing, pharmacogenomics, and genetic marker testing. As of July 2017, the company operates as a subsidiary of One Lambda, Inc., and has established a network of distributors in various countries, including Austria, Greece, Italy, and South Korea.

Patheon

Acquisition in 2017
Patheon Inc. is a global provider of commercial manufacturing and pharmaceutical development services tailored for the pharmaceutical and biotechnology sectors. Established in 1974 and headquartered in Mississauga, Canada, the company specializes in the production of prescription and over-the-counter products in various dosage forms, including solid, semi-solid, liquid, and sterile preparations. Patheon offers a comprehensive suite of services that encompasses the entire life cycle of pharmaceutical molecules, from early development phases to late-stage development and commercial manufacturing. Their capabilities include high-potency production, sterile manufacturing, lyophilization, and controlled-release formulations. Additionally, Patheon supports clients through contract development services, which involve pre-formulation, analytical method development, pilot batch manufacturing, clinical packaging, and technology transfer to ensure successful commercial-scale production. The company delivers its products and services to approximately 120 countries, enhancing the efficiency and effectiveness of drug development and commercialization for biopharmaceutical companies.

Core Informatics

Acquisition in 2017
Core Informatics, LLC is a software company based in Branford, Connecticut, that specializes in data management solutions aimed at enhancing scientific discovery and collaboration across various industries, including pharmaceuticals, environmental, and manufacturing sectors. Founded in 2005, the company offers a suite of products including Core LIMS, a laboratory information management system, and Core ELN, an electronic lab notebook for data management. Its Platform for Science serves as a comprehensive lab informatics platform that allows for the rapid configuration and deployment of various applications, supported by RESTful APIs for seamless integration with existing IT environments. Additionally, Core Informatics provides Core SDMS for instrument integration and automated data capture, and Core Collaboration, which facilitates secure information sharing among teams. Through these offerings, Core Informatics helps organizations derive valuable insights from their scientific data and build tailored workflows to address their specific needs.

Finesse Solutions

Acquisition in 2017
Finesse Solutions, Inc. specializes in manufacturing measurement and control solutions tailored for life sciences process applications. The company offers a range of products including single-use and sterilizable sensors, bioreactor controller hardware, and proprietary software designed to optimize upstream bio-processing workflows. Its TruBio software harmonizes equipment, aggregates data, and facilitates technology transfer, while its Smart technology suite includes solutions for optimizing bioproduction, enhancing cell growth environments, and ensuring reproducibility in batch processes. Finesse also provides rockers, stirred-tank glass vessels, equipment installation and validation services, as well as training for software, hardware, and sensor products. The company is strategically partnered with Alvotech and has established a global presence with offices in several countries, including China, the United Kingdom, South Korea, and Singapore, along with a customer service center in Massachusetts. Finesse Solutions was incorporated in 2005 and is headquartered in Santa Clara, California.

MTI-GlobalStem

Acquisition in 2016
MTI-GlobalStem has an active research program that utilizes expertise in transfection, neuroscience and stem cell biology to develop and supply scientists with the necessary tools and reagents to help advance new discoveries and developments in the life sciences. Utilizing our intellectual property and know-how, and a specialized team of highly skilled and experienced scientists, we are filling the gap with primary and iPSC-derived neural cells, stem cells and supporting feeder cells, optimized growth media and supplements, and an innovative platform of novel targeted reagents used to deliver nucleic acids into stem cells and neuronal cells with maximum efficiency.

FEI Company

Acquisition in 2016
FEI Munich specializes in advanced microscopy solutions, leveraging over 60 years of innovation in the field. The company designs and manufactures a wide array of high-performance microscopy systems that cater to micro-, nano-, and picometer-scale applications. FEI Munich is particularly focused on life sciences, providing products and services for fluorescence microscopy that are essential in fundamental research, applied science, and diagnostics. By offering comprehensive microscopy workflow solutions, the company enables customers to obtain critical insights and answers that facilitate significant discoveries and enhance productivity across various scientific domains.

INEL

Acquisition in 2016
INEL was incorporated in 1984 and converted into a joint venture in 1986 between Lucas Indian Service Ltd, a wholly-owned subsidiary of Lucas-TVS Ltd and MAHLE Electric Drives Japan Corporation, Japan - a company of MAHLE Group, Germany, to manufacture Electronic Ignition Systems for two-wheelers, three wheelers and portable engines. Over the years the company has enlarged its customer base and now supplies to most of the manufacturers of two-wheelers, three wheelers and gensets. Company's net sales for the year ended March, 2015 was Rs.3274 Million (USD 50 Million). INEL makes the entire range of 2/3 wheelers, digital and analog ignition products.

Affymetrix

Acquisition in 2016
Affymetrix is a company that specializes in developing and providing advanced technologies for the analysis of biological systems at the gene, protein, and cell levels. Its products are designed to facilitate genetic analysis within the life sciences and clinical healthcare markets. Affymetrix offers a range of life science tools and diagnostic products, including gene expression and genotyping services, which support both clinical diagnostics and research applications. By enabling comprehensive analysis of biological data, Affymetrix plays a significant role in advancing the understanding of molecular biology and improving healthcare outcomes.

Alfa Aesar

Acquisition in 2015
Alfa Aesar, a part of the Johnson Matthey group, is a prominent manufacturer and supplier of research chemicals, metals, and materials for diverse applications. With over 50 years of experience, the company provides high-purity raw materials essential for research and development. It offers an extensive product line that includes over 45,000 items, ranging from gram-scale catalog products to larger semi-bulk and bulk quantities. The offerings encompass inorganic, organic, and organometallic compounds, pure metals, precious metal compounds, biochemicals, fuel cell products, nanomaterials, and more. Alfa Aesar also specializes in custom manufacturing to meet specific customer needs. The company serves various sectors, including pharmaceutical and electronics industries, as well as academic institutions. Committed to product quality and customer service, Alfa Aesar ensures prompt availability and efficient delivery, with many catalog items available for same-day shipment. Their expertise, coupled with a robust quality assurance process, positions them as a trusted source for high-quality fine chemical products.

Advanced Scientifics (ASI)

Acquisition in 2015
Advanced Scientifics is a prominent global provider of advanced single-use systems tailored for the Healthcare and Life Sciences sectors. The company specializes in manufacturing customized systems and equipment that facilitate the preparation, processing, diagnostics, storage, and transportation of biopharmaceuticals. Headquartered in Pennsylvania, the company also operates an additional production facility in Matamoros, Mexico, enhancing its capacity to serve clients worldwide. Through its innovative offerings, Advanced Scientifics supports the growing demands of the bioprocessing industry.

Prionics

Acquisition in 2014
Prionics is a leading provider of diagnostic solutions for farm animals, specializing in a comprehensive range of tests to address various diseases, including zoonoses. The company has evolved from its origins as a pioneer in BSE testing to a one-stop provider that caters to the diagnostic needs of its international clientele. Prionics offers a variety of products, including diagnostic kits, tools for the electronic and visual identification of farm animals and pets, and forensic DNA sampling devices. Additionally, the company supplies biochemical reagents for both diagnostic and research purposes. By focusing on the food value chain and continuously enhancing its portfolio, Prionics aims to meet the unique challenges faced by customers in the agricultural sector, ensuring that its solutions are accessible globally.

Life Technologies

Acquisition in 2014
Life Technologies Corporation is a biotechnology tools company formed in November 2008 from the merger of Invitrogen Corporation and Applied Biosystems, Inc. The company operates under these well-known brands, providing a comprehensive range of systems, consumables, and services that facilitate scientific research and development. Invitrogen specializes in reagents and consumables applicable across various platforms, while Applied Biosystems offers integrated solutions in critical areas such as polymerase chain reaction (PCR), genetic sequencing, and mass spectrometry. Life Technologies' diverse product portfolio includes technologies for capillary electrophoresis-based sequencing, sample preparation, cell culture, RNA interference analysis, functional genomics, proteomics, and cell biology, in addition to applications in clinical diagnostics and water testing analysis. Through its offerings, Life Technologies supports researchers in accelerating their scientific endeavors.

picoSpin

Acquisition in 2012
picoSpin, LLC, based in Boulder, Colorado, was founded in 2010 by Charles E. Miller and a team of scientists and engineers. The company specializes in the development, manufacture, and marketing of miniature nuclear magnetic resonance (NMR) spectrometers. These compact instruments provide chemists with rapid and cost-effective access to analytical spectroscopy, making them valuable for quality analysis, quality control, chemical education, and process development. In addition to NMR spectrometers, picoSpin also produces replacement capillary cartridges and other fluid instruments tailored for the chemical engineering industry.

One Lambda

Acquisition in 2012
One Lambda is a manufacturer of transplant diagnostics products based in Los Angeles, California. The company specializes in developing and distributing a range of histocompatibility (HLA) typing tests that utilize both serological and molecular technologies. In addition to HLA typing tests, One Lambda produces a comprehensive array of antibody detection products and laboratory instrumentation. These offerings are designed to simplify and automate testing procedures, as well as facilitate final test evaluations, making them essential for pre and post-transplant monitoring.

Princeton Security Technologies

Acquisition in 2012
Princeton Gamma-Tech Instruments is a leading supplier of X-ray and Gamma-ray Detectors and Spectroscopy systems, portable Radioisotope Identifiers, and portable Chemical Analyzers. We serve a broad customer base in scientific research, industrial materials analysis, and Home Land Security. PGT operates a full customer service and Reachback program, backed by a modern manufacturing and service facility. Princeton Gamma-Tech has been a leader in the field of semiconductor gamma- and X-ray detectors for over 30 years. When General Electric first produced high-purity (intrinsic) germanium crystals in 1972-73, PGT manufactured the first commercial HPGe planar detectors, soon followed by the first HPGe coaxials. Since that time, PGT HPGe detectors have explored outer space, gone to the depths of mines in search of beta-beta decay in enriched germanium, and found uses throughout the world in nuclear power plants, environmental measurements, and aerospace studies.

Doe & Ingalls Management

Acquisition in 2012
Doe & Ingalls is a distributor of specialty chemicals, catering primarily to the life sciences and microelectronics sectors. The company provides a wide range of products, including cGMP buffer salts and solutions, nutrients, disinfectants, and cleaning solutions for biopharmaceutical processes. In addition to these offerings, Doe & Ingalls supplies photoresists, developers, strippers, edge bead removers, etchants, acids, solvents, and cleaners for electronic component manufacturing, as well as reagents for laboratory testing. Beyond its product distribution, the company aims to enhance supply chain security, robustness, and transparency for its customers by offering complementary supply chain services and market insights.

Intrinsic Bioprobes

Acquisition in 2011
Intrinsic Bioprobes is a biotechnology company based in Tempe, Arizona, established in 1996. The company specializes in the development and manufacture of immuno-enrichment and sample-preparation tools that are essential for quantitative mass spectrometry. In addition to these tools, Intrinsic Bioprobes creates clinical diagnostic assays and platforms aimed at rapid and sensitive analysis of protein biomarkers. The company also provides industrial-scale protein analysis services, focusing on the detection of proteins in human biological fluids, thereby supporting advancements in clinical diagnostics and research.

Trek Diagnostic Systems

Acquisition in 2011
TREK Diagnostic Systems, a part of Thermo Fisher Scientific, specializes in manufacturing automated systems and equipment for microbiology-based diagnostic testing. The company develops analytical instruments and innovative technologies for immune diagnostic testing, alongside solutions for air and water quality monitoring and process control. By providing essential tools and services, TREK Diagnostic Systems supports a variety of customers, including pharmaceutical and biotech companies, hospitals, clinical diagnostic laboratories, universities, research institutions, and government agencies. The overarching mission is to contribute to a healthier, cleaner, and safer world through advanced diagnostic and analytical capabilities.

Phadia

Acquisition in 2011
At Phadia, they develop, manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. For more than 40 years, they have been focused on delivering results, and they are proud to report that, in that time, they have maintained leadership in allergy testing and become one of the world's leading autoimmune disease test providers. Headquartered in Uppsala, Sweden, their international centre of excellence is at the heart of it all. The site of their strategic management, administration and business development activities, it’s also the home of extensive research and development as well as world-class manufacturing facilities. They also have a site in Southern Sweden, where development of their allergen raw materials takes place. In Freiburg, Germany, a third centre of excellence develops, manufactures and supports diagnostic tests for autoimmune diseases. Recently, a fourth centre of excellence was established in Vienna, Austria, to handle the development and production of assay systems, based on multiplex technology, for both allergy and autoimmunity. Together, these four centres enable us to remain focused on excellence as they respond to the diagnostic needs of the world.

Sterilin

Acquisition in 2011
Sterilin Limited is a manufacturer and supplier of disposable plastic products primarily serving the life science, microbiology, and clinical markets. The company specializes in single-use plastic ware, including petri dishes, sample containers, pipettes, and multiwell plates. In addition to its core offerings, Sterilin provides a variety of packaging solutions, featuring regular bottles made from materials such as HDPE, LDPE, and polypropylene, which come with various closure options including dispensing, child-resistant, and tamper-evident features. The product range also includes moulded and extruded silicone items like cones, discs, pipette bulbs, sheeting, stoppers, test tube holders, and tubing, catering to diverse laboratory and clinical needs.

TKA Wasseraufbereitungssysteme

Acquisition in 2010
TKA Wasseraufbereitungssysteme GmbH specializes in laboratory water purification systems, offering a range of products designed for high-quality water treatment. Its portfolio includes ion exchange cartridges, reverse osmosis systems, ultrapure water systems, and water softeners. The company is also involved in the design and manufacture of various water purification equipment, including mixed-bed ionizers and pretreatment systems. In addition to these core products, TKA Wasseraufbereitungssysteme provides accessories such as mixed-bed resins, activated carbon filters, and measuring instruments, catering to the diverse needs of laboratory environments.

Dionex

Acquisition in 2010
Dionex Corporation specializes in the development, manufacturing, and servicing of chromatography and extraction systems designed for the separation, isolation, and identification of components within chemical mixtures. The company's chromatography equipment is utilized globally across various sectors, including environmental analysis, life sciences, pharmaceuticals, food and beverage, chemicals, power generation, and electronics. By providing advanced solutions, Dionex enhances productivity for industries critical to global infrastructure and health.

Lomb Scientific

Acquisition in 2010
Lomb Scientific is a leading supplier of laboratory consumables, chemicals, and instrumentation to the scientific community, with a core manufacturing facility located in Western Sydney and a distribution center in Southern Sydney. Originally established as a niche manufacturer of microscope slides and coverslips, the company has significantly expanded under the leadership of Walter Parsons since its acquisition in 1984. Lomb Scientific has enhanced its operations through strategic acquisitions, including Scot Scientific, Fronine, and Ajax Finechem, which have improved its coverage, manufacturing capabilities, and exclusive product offerings. With facilities and sales offices across Australia and New Zealand, Lomb Scientific aims to support the advancement of science by providing a comprehensive range of high-quality products.

Fermentas International

Acquisition in 2010
With origins dating back to the 1970s, Fermentas produced molecular biology products for scientific research. Fermentas grew to be the dominant player in Europe, and sought an experienced life sciences partner to solidify this leading position while helping expand geographically into North America and Asia.

Polychromix

Acquisition in 2010
Polychromix is an advanced communications technology company specializing in modular optical subsystems. It develops and manufactures innovative products for material analysis and chemical sensing, including the PHAZIR, a near-infrared material analyzer. The PHAZIR is designed for various applications such as incoming raw material inspection, quality control and assurance, portable field use, counterfeit product identification, and at-line process control. Polychromix's core technologies facilitate the creation of dynamically configurable optical networks, enhancing its offerings in the field of material analysis and optical communication.

Proxeon

Acquisition in 2010
Proxeon specializes in developing innovative solutions for the field of proteomics, addressing various scientific and technical challenges. With over 15 years of experience in proteomics research, the company has established a strong reputation for creating high-quality products. Proxeon focuses on mass spectrometry, protein analysis, and the design of both hardware and software tailored for proteome analysis. Their offerings include medical devices for sample purification, which enhance proteomic workflows by emphasizing performance, robustness, simplicity, and user-friendliness. By leveraging their extensive expertise, Proxeon contributes to advancing proteomics tools and technologies.

NovaWave Technologies

Acquisition in 2010
NovaWave Technologies, founded in 2002, specializes in the development of optically-based chemical detection instrumentation and chemical sensors for various applications, including environmental monitoring, industrial safety, and military use. The company also focuses on creating novel microfluidic systems aimed at enhancing clinical diagnostics and biological agent detection. With a team composed of experienced scientific, management, and marketing professionals, NovaWave has established strategic partnerships with industry leaders, facilitating the rapid production of cost-effective, high-performance sensor systems. These collaborations enable the company to effectively serve both military and civilian markets while advancing its mission in chemical detection and instrumentation.

Finnzymes Oy

Acquisition in 2010
Finnzymes Oy specializes in the development and manufacturing of scientific instruments and high-quality enzymes for molecular biology applications. Established in 1986, the company is recognized for its expertise in polymerase chain reaction (PCR) technologies, including reverse transcription-PCR (RT-PCR) and real-time quantitative PCR (qPCR). Finnzymes aims to enhance the performance of these enzymes to support various applications, such as genomic research, genetic testing, forensics, and food testing. The company emphasizes ongoing research and development to provide innovative tools that meet the needs of the molecular biology community. With a strong foundation in scientific excellence, Finnzymes also offers competitive pricing and responsive technical support, contributing to its reputation as a leader in enzyme innovation in Finland.

Ahura Scientific

Acquisition in 2010
Ahura Scientific Inc. specializes in developing portable optical systems designed for the real-time identification and authentication of liquid and solid chemical substances. The company produces handheld Raman spectrometers that are utilized for raw material identification and finished product verification, particularly in the pharmaceutical and consumer health sectors. Their products are also employed in applications related to chemical and explosive identification, material verification, anti-counterfeiting, and medical devices. Manufactured in an ISO 9001-certified facility in the USA, Ahura Scientific's offerings are tailored for customers across various sectors, including homeland security, life sciences, and industrial markets, ensuring exceptional portability and performance.

B.R.A.H.M.S.(Brahms)

Acquisition in 2009
B.R.A.H.M.S. specializes in the development and production of diagnostic test procedures aimed at enhancing the diagnosis and treatment of life-threatening illnesses. With a workforce of over 400 employees, the company utilizes its patented biomarkers to deliver superior diagnostic insights for both patients and medical professionals. B.R.A.H.M.S. focuses on various medical applications, including bacterial infections, sepsis, cardiovascular disease, and neurological disorders. Its products are distributed in over 65 countries, establishing the company as a leader in its specialized markets.

Biolab

Acquisition in 2009
Biolab Limited supplies laboratory products and analytical technologies to clients in Australia and New Zealand. It offers clinical diagnostic testing products, diagnostic imaging products, environmental monitoring and safety products, medical devices and consumables, process monitoring and industrial instruments, laboratory chemicals, laboratory equipment and furniture, life science research technologies, microbiology products, pathology equipment and supplies, and scientific instruments and automation solutions, as well as laboratory plasticware, glassware, and supplies.

ABR--Affinity BioReagents

Acquisition in 2008
ABR--Affinity BioReagents, Inc. is a manufacturer and distributor of monoclonal and polyclonal antibodies, as well as recombinant proteins, primarily serving the scientific research community. Based in Golden, Colorado, the company offers a wide range of products, including those related to cell biology, such as apoptosis and cell adhesion markers, as well as cell signaling components like bioactive peptides and various receptors. Additionally, ABR provides reagents and immunology services, catering to diverse fields including muscle biology, nuclear biology, neurobiology, and stem cell biology. The company's products are marketed globally through a network of distribution partners in numerous countries, ensuring broad accessibility to its offerings. Founded in 1989, ABR operates as a subsidiary of Pierce Biotechnology Inc.

NanoDrop Technologies

Acquisition in 2007
NanoDrop Technologies specializes in the manufacturing and sale of analytical instruments that utilize patented sample retention technology. Based in Wilmington, Delaware, the company produces micro-volume ultraviolet-visible spectrophotometers and fluorospectrometers, which are designed to analyze small sample volumes of just 1 microliter. These instruments are widely used in biotechnology, pharmaceutical, and life science research laboratories around the world. The innovative sample retention technology was developed in the DuPont Agricultural Genomics Laboratories and has been in operation since 1998, providing researchers with reliable and efficient tools for their analytical needs.

Priority Solutions International

Acquisition in 2007
Priority Solutions International specializes in global supply chain management, primarily serving the pharmaceutical, consumer healthcare, and testing industries. The company provides a range of logistics services, including warehousing, order management, shipment preparation, and reverse logistics. Additionally, it offers regulatory compliant distribution services, which encompass the handling of controlled substances and emergency response services, as well as international and airfreight solutions.

Cohesive Technologies

Acquisition in 2007
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.

Spectronex

Acquisition in 2007
Spectronex is a leading supplier of mass spectrometry, chromatography and surface science instrumentation in Switzerland, Austria, Slovakia and the Czech Republic.

Flux Instruments

Acquisition in 2007
In 1992 Flux Instruments was founded in the small industrial town of Karlskoga in Sweden. The founders predicted an increasing potential for their novel HPLC pump, based on a radically new concept. It's secret? Hitherto unknown miniaturization techniques lead to unsurpassed precision and microflow capabilities. With its R&D department near Munich in Germany and its manufacturing site in Sweden and Switzerland. Technology leadership and precision manufacturing have been given the highest priority. They will continue their innovative strategies and make sure to also fulfill your needs in the years to come. High-Pressure-Liquid-Chromatography has outstanding worldwide growth, probably outperforming all other types of analytical instruments. In combination with MS has, the use of microbore and capillary columns already are state-of-the-art, other areas in HPLC are likely to follow. The necessity to deliver gradient HPLC flow in the low micro-and even nanoliter range has been their challenge from the beginning. Today they offer the No. 1 system for microbore HPLC and have clear leadership in this market segment. Whether for applications in life sciences, in proteomics research, or in the area of high throughput analysis and fast analysis cycles, the miniaturized design of their instruments is the key to outstanding performance.

SwissAnalytic Group

Acquisition in 2007
SwissAnalytic Group develops and markets liquid chromatography pumps.

EGS Gauging

Acquisition in 2006
EGS Gauging Inc is one of the world's largest suppliers of measurement and control products for web process applications in the plastics processing and converting industries. They have the resources and the vision to bring their customers into the future with a full complement of innovative web gauging and control systems and services. But the proof is in the numbers: With almost 3000 EGS Gauging systems installed worldwide, and a higher than 75% repeat business rate, the clear message from OEMs and users is that EGS Gauging solutions continue to be the clear choice for quality, reliability, performance and results. From the Americas to Zimbabwe, and more than 50 countries in between, EGS Gauging systems are hard at work delivering top-of-the-line measurement performance for plants of all sizes.

Omega Data Systems

Acquisition in 2006
Netherlands-based Omega Data Systems, developer of the world renowned UniQuant XRF analysis package. UniQuant® is software for use with a sequential X-Ray Fluorescence (XRF) Spectrometer. It enables quantitative elemental analysis of samples without or with the use of standards.

Fisher BioImage

Acquisition in 2006
Fisher BioImage ApS, a life science company, develops and sells assays for monitoring protein translocations and protein interactions in living cells. It provides Redistribution technology, which helps to monitor cell-based protein translocation assays using fluorescent protein reporters. The company offers assays to pharmaceutical and biotechnology companies, as well as to academic groups for basic research.

Ambion

Acquisition in 2006
Ambion is an online retailer specializing in RNA-based reagents and molecular biology products for life science research. The company provides a range of offerings, including enzymes and products related to drug development and other RNA-based applications. With a focus on supporting scientific research, Ambion serves as a resource for researchers in the life sciences sector, supplying essential tools and materials for various studies and experiments.

Ionalytics Corporation

Acquisition in 2005
Sensitivity, separation and detection are critical success factors in drug discovery. At Ionalytics, they have developed the Ionalytics SelectraTM, a front-end instrument that enhances the performance of mass spectrometers by providing dynamic ion filtering to: - improve efficacy of data - reduce drug development time Based on FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) technology, the Ionalytics Selectra filters and focuses ions within a highly tuned electrical field contained within an electrode set. The result is increased productivity of mass spectrometers in both qualitative and quantitative applications. The Ionalytics team is committed to providing innovative tools to help laboratory professionals determine a drug's potential for treating or curing illness. Comprised of seasoned business leaders, respected scientists and engineers with years of product development and support expertise, their collective talent and experience has resulted in a customer-oriented culture and a high performance instrument that helps bring new drugs to market quicker.

Rupprecht & Patashnick

Acquisition in 2005
Rupprecht & Patashnick, founded in 1981 and headquartered in East Greenbush, New York, is recognized globally for its innovative and reliable high-performance instrumentation tailored for continuous particulate monitoring. The company has built a strong reputation within the regulatory landscape, developing products that meet stringent environmental standards. With a workforce of over 100 employees, R&P specializes in instrumentation that monitors air quality, positioning itself as a leader in this critical field. The company is set to become part of the Air Quality Instruments product line within Thermo's Environmental Instruments division, further enhancing its capabilities and reach in the environmental monitoring sector.

Kendro Laboratory Products

Acquisition in 2005
Kendro Laboratory Products is a global leader in providing sample preparation products and services tailored for life sciences, material sciences, and drug discovery applications. The company designs, manufactures, and markets a diverse range of laboratory equipment essential for sample preparation, processing, and storage, primarily utilized in life sciences and clinical laboratories. Kendro's centrifuge products, recognized by brands such as Sorvall and Heraeus, facilitate various applications, including DNA and whole cell separation for biochemistry, molecular biology, and diagnostics. Additionally, the company offers thermal equipment, including ovens, incubators, freezers, and refrigerators, marketed under the Revco and Jewett brands. Beyond equipment, Kendro delivers comprehensive services through a global network of technicians, providing integrated validation services and bio-repositories for sample storage and laboratory relocation management.

Oxoid

Acquisition in 2004
Oxoid, headquartered in Basingstoke, England, is a prominent manufacturer of microbiological culture media and diagnostic products. The company operates across Europe, North and South America, and Australia, providing essential tools for microbiology laboratories, food testing, and biopharmaceutical production. Oxoid's products are critical for isolating and identifying bacteria and other organisms, ensuring the safety and quality of food and medical products. With a strong commitment to quality and customer service, Oxoid has established a solid reputation in the industry for helping clients maintain their products free from bacterial contamination.

Dharmacon

Acquisition in 2004
Based in Lafayette, Colo., Dharmacon, Inc. is a leading provider of reliable and high quality RNA oligonucleotides, small interfering RNA (siRNA) and related RNA-interference (RNAi) products and technologies to the life-sciences industry. Using its core expertise in chemistry, biology, bioinformatics and production, Dharmacon has pioneered a custom siRNA design service for maximizing the efficiency of gene silencing, a powerful and increasingly widely-used new technology based on siRNA.

Jouan SA

Acquisition in 2003
Jouan is a global supplier of products used by life science researchers in academic, pharmaceutical, biotech, and clinical markets to prepare and preserve laboratory samples. Jouan's offerings include centrifuges, biological safety cabinets, ultra-low temperature freezers, and incubators. The company has also incorporated robotics into many of its products to meet the increased throughput requirements of researchers, and is a leading provider of automated centrifuges, freezers, and incubators. In addition to its own brand name, Jouan's products are sold worldwide under the Precision, NAPCO, Heto, Holten, and ALC brands. Jouan is based in Saint-Herblain, France, and has manufacturing operations in France, Denmark, Italy, the Czech Republic, and the U.S.

Perbio Science

Acquisition in 2003
Perbio Science AB is a biotechnology company based in Helsingborg, Sweden, specializing in protein-related products and services. It caters primarily to life science researchers and biopharmaceutical companies, enabling them to understand and produce proteins more efficiently and economically. The company is organized into three divisions: the Bioresearch Division offers kits, reagents, and services for protein identification, quantification, purification, and modification, as well as components for nucleic acid-based drugs and diagnostics. The Cell Culture Division provides essential nutrition for animal cell cultures, along with process liquids for protein purification and sterile liquid handling systems. The Medical Device Division focuses on solutions for the ears, nose, and throat, particularly in voice rehabilitation for laryngectomized patients. With a workforce of 1,314 employees as of March 31, 2003, Perbio Science is committed to advancing medical and biopharmaceutical innovations that contribute to improved quality of life for humans and animals.

CRS Robotics

Acquisition in 2002
CRS develops laboratory integration hardware and software to control motion control devices (robots). The company designs, manufactures and markets integrated laboratory workstations, laboratory peripheral products and articulated robots for a variety of laboratory and advanced manufacturing processes. Their core competence is the provision of standard automation solutions utilizing advanced proprietary software for the multi-billion dollar world biotechnology and pharmaceutical segments of the global Life Sciences market. CRS advanced software and motion control devices are used for drug discovery, gene sequencing, quality assurance and compound testing. In addition, they supply robot automation products to niche advanced manufacturing and technology markets such as product and materials testing, machine and instrument loading, dispensing and deburring, applications, and for Research and Development and Educational Institutions. CRS is a global company with sales, service and engineering centers throughout the global marketplace.

Keystone Scientific

Acquisition in 2000
Keystone was founded in 1985 by Dr. Richard A. Henry, a highly respected chromatographer with 30 years of experience, and Director of Analytical Laboratories at Penn State University. Dr. Henry is still active in the company as Technical Director, where he sets a high standard for technical support and development of innovative products. Keystone specializes in preparing packed columns for HPLC, SFC and CEC, plus the supplies and accessories that allow columns to be used properly. KSI now occupies various buildings and employs many competent, experienced chemists. The different departments of KSI work together to provide the customer with a high quality product, fast service, excellent customer service and technical support.

Thermo Hypersil-Keystone

Acquisition in 2000
Thermo Hypersil-Keystone LLC manufactures and supplies instrumentation and laboratory equipment such as packed columns and accessories for chromatography; general purpose, base deactivated, reversed and normal phase, and specialty columns for the analysis of proteins, peptides and biomolecules.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.